XML 36 R25.htm IDEA: XBRL DOCUMENT
v3.25.3

Restructuring Charges and Other Costs Associated with Acquisitions and Cost-Reduction/Productivity Initiatives (Tables) | 9 Months Ended
--- | ---
Sep. 28, 2025
Restructuring and Related Activities [Abstract] |
Schedule of Acquisitions and Cost-Reduction/Productivity Initiatives |
The following summarizes costs and credits for acquisitions and cost-reduction/productivity initiatives:
|  | Three Months Ended |  | Nine Months Ended
(MILLIONS) |  | September 28, 2025 |  | September 29, 2024 |  | September 28, 2025 |  | September 29, 2024
Restructuring charges/(credits): |  |  |  |  |  |  |  |
Employee terminations |  | $ | 124 |  |  | $ | 25 |  |  | $ | 360 |  |  | $ | 1,009 |
Asset impairments |  | 111 |  |  | 111 |  |  | 328 |  |  | 177 |
Exit costs |  | 2 |  |  | 82 |  |  | 96 |  |  | 145 |
Restructuring charges/(credits)(a) |  | 237 |  |  | 217 |  |  | 784 |  |  | 1,331 |
Transaction costs(b) |  | — |  |  | — |  |  | — |  |  | 5 |
Integration costs and other(c) |  | 49 |  |  | 96 |  |  | 162 |  |  | 333 |
Restructuring charges and certain acquisition-related costs |  | 286 |  |  | 313 |  |  | 945 |  |  | 1,669 |
Net periodic benefit costs/(credits) recorded in Other (income)/deductions––net |  | (6) |  |  | 2 |  |  | (74) |  |  | 7 |
Inventory write-offs––recorded in Cost of sales |  | 33 |  |  | — |  |  | 33 |  |  | — |
Additional depreciation––asset restructuring recorded in our condensed consolidated statements of operations as follows(d): |  |  |  |  |  |  |  |
Cost of sales |  | 3 |  |  | 6 |  |  | 10 |  |  | 11 |
Selling, informational and administrative expenses |  | — |  |  | 2 |  |  | — |  |  | 5 |
Research and development expenses |  | 1 |  |  | — |  |  | 1 |  |  | — |
Total additional depreciation––asset restructuring |  | 4 |  |  | 8 |  |  | 11 |  |  | 16 |
Implementation costs recorded in our condensed consolidated statements of operations as follows(e): |  |  |  |  |  |  |  |
Cost of sales |  | 26 |  |  | 30 |  |  | 72 |  |  | 95 |
Selling, informational and administrative expenses |  | 26 |  |  | 13 |  |  | 46 |  |  | 77 |
Research and development expenses |  | 53 |  |  | 33 |  |  | 116 |  |  | 66 |
Total implementation costs |  | 105 |  |  | 75 |  |  | 234 |  |  | 238 |
Total costs associated with acquisitions and cost-reduction/productivity initiatives |  | $ | 423 |  |  | $ | 398 |  |  | $ | 1,150 |  |  | $ | 1,930 |
(a)Primarily represents cost-reduction initiatives. Amounts associated with our Biopharma segment: (i) charges of $240 million for the three months ended September 28, 2025 (including charges of $117 million for our Manufacturing Optimization Program and charges of $107 million for our Realigning our Cost Base Program), (ii) charges of $451 million for the nine months ended September 28, 2025 (including charges of $669 million for our Realigning our Cost Base Program and credits of $295 million for our Manufacturing Optimization Program), (iii) charges of $141 million for the three months ended September 29, 2024 (primarily including charges for our Realigning our Cost Base Program) and (iv) charges of $1.2 billion for the nine months ended September 29, 2024 (including charges of $1.3 billion for our Manufacturing Optimization Program and credits of $69 million for our Realigning our Cost Base Program). For the nine months ended September 28, 2025 and September 29, 2024, Employee terminations include revisions of estimates of previously recorded accruals for severance benefits, driven in large part by higher-than-expected voluntary attrition. (b)Represents external costs for banking, legal, accounting and other similar services. (c)Represents external, incremental costs directly related to integrating acquired businesses, such as expenditures for consulting and the integration of systems and processes, and certain other qualifying costs. (d)Represents the impact of changes in the estimated useful lives of assets involved in restructuring actions. (e)Represents incremental costs directly related to implementing our non-acquisition-related cost-reduction/productivity initiatives.
Schedule of Components and Changes in Restructuring Accruals |
The following summarizes the components and changes in restructuring accruals:
(MILLIONS) |  | Employee Termination Costs |  | Asset Impairment Charges |  | Exit Costs |  | Accrual
Balance, December 31, 2024(a) |  | $ | 2,046 |  |  | $ | — |  |  | $ | 74 |  |  | $ | 2,120 |
Provision |  | 360 |  |  | 328 |  |  | 96 |  |  | 784 |
Utilization and other(b) |  | (724) |  |  | (328) |  |  | (15) |  |  | (1,067) |
Balance, September 28, 2025(c) |  | $ | 1,682 |  |  | $ | — |  |  | $ | 155 |  |  | $ | 1,836 |
(a)Included in Other current liabilities ($1.7 billion) and Other noncurrent liabilities ($437 million). (b)Other activity includes adjustments for foreign currency translation that are not material to our condensed consolidated financial statements. (c)Included in Other current liabilities ($1.3 billion) and Other noncurrent liabilities ($532 million).

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 5.P.3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 + Details
Name: | us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4.b.2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 + Details
Name: | us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration